# reload+after+2024-01-22 13:44:26.245873
address1§6005 Hidden Valley Road
address2§Suite 110
city§Carlsbad
state§CA
zip§92011
country§United States
phone§858 293 4900
website§https://www.designtx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs. It is also developing GeneTAC product candidate portfolio for the treatment of other nucleotide repeat expansion-driven monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and spinobulbar muscular atrophy. The company was incorporated in 2017 and is headquartered in Carlsbad, California.
fullTimeEmployees§57
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Pratik  Shah Ph.D.', 'age': 53, 'title': 'Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 638460, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Sean  Jeffries Ph.D.', 'age': 43, 'title': 'Chief Operating Officer', 'yearBorn': 1980, 'fiscalYear': 2022, 'totalPay': 572210, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Aseem Z. Ansari Ph.D.', 'title': 'Co-Founder & Scientific Advisor', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Julie D. Burgess CPA', 'title': 'Chief Accounting Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Elizabeth  Gordon Ph.D.', 'title': 'Senior Vice President of Regulatory Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jae B. Kim FACC, M.D.', 'age': 53, 'title': 'Chief Medical Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Dawn  Giangiulio', 'title': 'Controller', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§8
compensationRisk§9
shareHolderRightsRisk§8
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.659
currency§USD
dateShortInterest§1702598400
forwardEps§-1.4
exchange§NMS
quoteType§EQUITY
shortName§Design Therapeutics, Inc.
longName§Design Therapeutics, Inc.
firstTradeDateEpochUtc§1617024600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§334bfad0-1826-3cb5-ba7e-3a834e43b6bd
gmtOffSetMilliseconds§-18000000
targetHighPrice§6.0
targetLowPrice§4.0
targetMeanPrice§4.75
targetMedianPrice§4.5
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§4
quickRatio§23.579
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
